Pison

Pison and The Honor Foundation Partner to Empower U.S. Special Operations Forces Veterans as they Transition from Military to Civilian Sector

Retrieved on: 
星期三, 四月 17, 2024
Pison, Special operations, THF, Traumatic brain injury, GEICO, Health, Talladega Superspeedway, Partnership, TBI, NASCAR, Fatigue, SOCOM, Organization, Veteran

BOSTON, April 17, 2024 /PRNewswire/ -- Pison, the trailblazer in AI-powered neural sensors for cognitive health, wellness, and gesture control, today announced a strategic partnership with The Honor Foundation (THF), a unique career transition institute that serves U.S. Special Operations Forces (SOF) by providing a clear process for their transition from military to civilian lives, so that their mission is always clear and continues to impact the world.

Key Points: 
  • "The Honor Foundation is excited to partner with Pison Technology and very grateful for their support.
  • They share our commitment to empowering high performers and their work aligns well with our mission to support our Special Operations Forces veterans as they enter civilian life," said Matt Stevens, CEO of The Honor Foundation.
  • "Pison is a proud employer of former members of the Special Operations forces and an alumnus of THF.
  • Throughout the partnership, Pison will demonstrate its commitment by donating a portion of all sales generated through the partnership to The Honor Foundation.

Pison Technology Appoints Industry Experts to C-Suite, Prepares to Address New Markets

Retrieved on: 
星期二, 九月 26, 2023
Consumer Electronics, Health, Technology, Other Technology, Software, General Health, Artificial Intelligence, Endeca, Software as a service, Partnership, Nokia, Marketing, Internet of things, Record, Multimedia, Ericsson, Research, CMO, Harvard Medical School, Athlete, Acorn, InterSystems, Engineering, Growth, Hospital, AI, MPH, CPO, Pison, Management, Brigham, MD

These key leadership appointments are vital developments as Pison prepares to launch groundbreaking cognitive performance products for competitive athletes and professional knowledge workers, while it continues to refine its groundbreaking gesture capabilities for spatial computing.

Key Points: 
  • These key leadership appointments are vital developments as Pison prepares to launch groundbreaking cognitive performance products for competitive athletes and professional knowledge workers, while it continues to refine its groundbreaking gesture capabilities for spatial computing.
  • “We are honored to have Bill, Cris and John join Pison, ” said John Croteau, CEO of Pison Technology.
  • “They bring many decades of proven experience and track records of success for deterministic execution of our new company strategy.
  • We couldn’t be more excited about the new products, services, and partnerships that we’re readying to launch after the New Year.”
    To learn more about Pison Technology, visit www.pison.com .

Landmark Study Finds Pison AI Technology Can Detect Neurological Disorder in ALS Patients

Retrieved on: 
星期二, 四月 18, 2023
Science, Neurology, Other Science, Research, Health, Artificial Intelligence, Technology, Other Technology, Temple University, Electromyography, ENG, Deep learning, National Science Foundation, Clinical trial, DSM-IV codes, Data collection, Temple, Fasciculation, Multiple sclerosis, Disorder, ALS Association, Associate, Harvard Medical School, The, Iran National Science Foundation, HIV disease progression rates, Patient, ALS Functional Rating Scale - Revised, FRS, Algorithm, Diagnosis, Hospital, ALS, Disease, Medical imaging, Pison, Brigham, Medicine

These results demonstrate that Pison’s technology has the potential to become a digital biomarker to detect neurological diseases, monitor progression, and inform treatment.

Key Points: 
  • These results demonstrate that Pison’s technology has the potential to become a digital biomarker to detect neurological diseases, monitor progression, and inform treatment.
  • The study found that Pison’s technology could distinguish between patients diagnosed with ALS and a healthy population.
  • The technology demonstrated that it could detect fasciculations and differentiation between healthy people and people living with ALS in a resting state using deep learning algorithms.
  • “This clinical result is an important step towards receiving regulatory approval for medical applications of Pison technology.

Pison Technology Appoints John Croteau as CEO

Retrieved on: 
星期三, 十二月 7, 2022
Consumer Electronics, Health, Technology, Fitness & Nutrition, Mobile, Wireless, Software, General Health, Electricity, Heart, Dell, Analog Devices, Computer, LED, DSP, Algorithm, Software, Fitness, Microsoft Windows, NXP, Pison, IBM, HP, ALS Association, Semiconductor, Patient, ADI, GPS, Neurodegeneration, ENG, Wrist, Intel, ALS, Human, Microsoft, Bell Labs, Multimedia, Senior, National Science Foundation, Natural language, Brain, Cirrus Logic, Health, Machine learning, Processor, Nervous system, Massachusetts Institute of Technology, Compaq, Management, Consumer electronics, Mobile phone, Metaverse, Anne-Marie Croteau

Johns progress forging partnerships and embedding Pison machine learning technology in semiconductor components and consumer devices has exceeded all expectations.

Key Points: 
  • Johns progress forging partnerships and embedding Pison machine learning technology in semiconductor components and consumer devices has exceeded all expectations.
  • As CEO, Croteau is responsible for facilitating partnerships with global tech leaders to bring Pison ENG technology to consumers.
  • Croteau has 37 years of experience working for global semiconductor leaders and joined Pison in January 2022.
  • We championed data conversion technology from Bell Labs that is, today, at the heart of every Pison Neural Biosensor.

Pison Technology Closes $7M Series A Round

Retrieved on: 
星期二, 三月 23, 2021
Crabronidae, Pison, Productivity-improving technologies, Digital

Pison captures neuromuscular signals on the surface of the skin and combines them with machine learning algorithms to enable the intuitive, productive, and hands-free control of electronics.

Key Points: 
  • Pison captures neuromuscular signals on the surface of the skin and combines them with machine learning algorithms to enable the intuitive, productive, and hands-free control of electronics.
  • Pison touchless control is the next stage in the evolution of human influence over the digital world.
  • "The next phase for Pison will be releasing our gesture technology to improve lives, safety, and productivity across multiple industries."
  • Pison technology unlocks access to the physical and digital world by leveraging neurological insights, and its insights platform supports innovations in medicine, sports performance, and general wellness.

Pison Stream Solutions Gains Approval for Coatings by U.S. Military Laboratory

Retrieved on: 
星期四, 八月 27, 2020
Military technology, Crabronidae, Pison, United States Army Research Laboratory, CARC

This prestigious designation officially places Pison on the U.S. Government's Qualified Products Database by the U.S. Department of Defense (DoD) Army Research Laboratory, which manages, tests and qualifies manufacturers who can produce military specification coatings for U.S. military applications.

Key Points: 
  • This prestigious designation officially places Pison on the U.S. Government's Qualified Products Database by the U.S. Department of Defense (DoD) Army Research Laboratory, which manages, tests and qualifies manufacturers who can produce military specification coatings for U.S. military applications.
  • CARC applies to various military vehicles, tanks, personnel carriers, equipment transporters, and other military components and assets.
  • Pison Stream Solutions (pronouncedPieSun) founded in 2010, is a multi-platform, highly engineered, innovative coatings and green technology, research and development corporation.
  • The Pison Stream Solutions corporation operates from their Centre of Expertise and R&D Laboratory in Greater Cleveland, Ohio and Pison Global Headquarters from One World Trade in New York City.